These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18657584)

  • 1. Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines.
    Xu R; Megati S; Roopchand V; Luckay A; Masood A; Garcia-Hand D; Rosati M; Weiner DB; Felber BK; Pavlakis GN; Sidhu MK; Eldridge JH; Egan MA
    Vaccine; 2008 Sep; 26(37):4819-29. PubMed ID: 18657584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.
    Kanagavelu SK; Snarsky V; Termini JM; Gupta S; Barzee S; Wright JA; Khan WN; Kornbluth RS; Stone GW
    Vaccine; 2012 Jan; 30(4):691-702. PubMed ID: 22146759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.
    Bolesta E; Kowalczyk A; Wierzbicki A; Eppolito C; Kaneko Y; Takiguchi M; Stamatatos L; Shrikant PA; Kozbor D
    J Immunol; 2006 Jul; 177(1):177-91. PubMed ID: 16785513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
    Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
    J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Immune Responses against HIV-1 with Adenovector (Gag and Tat) Prime/Protein Boost Regimen and GM-CSF Injection.
    Hosseini Rouzbahani N; Bayanolhagh S; Gholami M; Esmaeilzadeh A; Bayat Jozani Z; Mohraz M; Pourfathollah AA
    Iran J Allergy Asthma Immunol; 2016 Oct; 15(5):403-412. PubMed ID: 27917627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.
    Qiu JT; Chang TC; Lin CT; Chen YM; Li FQ; Soong YK; Lai CH
    Vaccine; 2007 Jan; 25(2):253-63. PubMed ID: 16971027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
    Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
    Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells.
    Muthumani G; Laddy DJ; Sundaram SG; Fagone P; Shedlock DJ; Kannan S; Wu L; Chung CW; Lankaraman KM; Burns J; Muthumani K; Weiner DB
    Immunology; 2009 Sep; 128(1 Suppl):e612-20. PubMed ID: 19740322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.
    Santana VC; Almeida RR; Ribeiro SP; Ferreira LC; Kalil J; Rosa DS; Cunha-Neto E
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1010-6. PubMed ID: 26602876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
    Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.
    Rodríguez AM; Pascutti MF; Maeto C; Falivene J; Holgado MP; Turk G; Gherardi MM
    PLoS One; 2012; 7(5):e37801. PubMed ID: 22655069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
    Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C
    APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.
    Perdiguero B; Sánchez-Corzo C; Sorzano COS; Saiz L; Mediavilla P; Esteban M; Gómez CE
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30781504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.
    Moore AC; Kong WP; Chakrabarti BK; Nabel GJ
    J Virol; 2002 Jan; 76(1):243-50. PubMed ID: 11739689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of retroviral envelope with vaccine-induced CD8
    Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W
    Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
    Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
    Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
    Maksaereekul S; Dubie RA; Shen X; Kieu H; Dean GA; Sparger EE
    Vaccine; 2009 Jun; 27(28):3754-65. PubMed ID: 19464559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection.
    Encke J; Bernardin J; Geib J; Barbakadze G; Bujdoso R; Stremmel W
    World J Gastroenterol; 2006 Nov; 12(44):7118-25. PubMed ID: 17131473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.